Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma

F. Marmont, A. Pich, L. Chiusa, F. Locatelli, M. Falda, M. Boccadoro, L. Resegotti

Research output: Contribution to journalArticle

Abstract

The correlation between the bromodeoxyuridine (BrdU)-labelling index (LI) of plasma cells and a new proliferation marker, the Argyrophilic Nucleolar Organizer Regions (AgNORs), was investigated in 44 myeloma patients at diagnosis. A preliminary analysis was made to verify the reproducibility of the assessment of plasma cell infiltration (PC%) in bone marrow aspirates, used to collect cells for LI determination, and in bone marrow biopsies, used for AgNORs evaluation. Although an overall good correlation was observed between PC% in biopsies and aspirates (r = 0.58, p = 0.001), the ratio between PC% in biopsies and in aspirates ranged from 0.35 to 7.5. Only 17 patients (38.6%) were within the 0.5-1.5 range. A positive correlation between LI and AgNORs was observed in these patients (r = 0.68, p = 0.003), whereas the correlation was lost in patients with higher ratio between PC% in biopsies and in aspirates (r = 0.08, p = 0.69). The prognostic significance of AgNORs was confirmed by survival analysis, showing a reduced survival for patients with high (> 4.4) AgNOR counts (14 months vs 35 months, p = 0.004). The AgNORs analysis therefore allows the simultaneous evaluation of myeloma cell infiltration, degree of differentiation and kinetics of growth in bone marrow biopsies. AgNOR counts deserve to be included in the procedures for diagnosis and prognostic evaluation of myeloma patients.

Original languageEnglish
Pages (from-to)39-44
Number of pages6
JournalEuropean Journal of Haematology
Volume56
Issue number1-2
Publication statusPublished - 1996

Fingerprint

Nucleolus Organizer Region
Multiple Myeloma
Plasma Cells
Biopsy
Bone Marrow
Bromodeoxyuridine
Survival Analysis
Survival
Growth

Keywords

  • AgNORs
  • BrdU labelling index
  • Multiple myeloma
  • Prognosis

ASJC Scopus subject areas

  • Hematology

Cite this

Marmont, F., Pich, A., Chiusa, L., Locatelli, F., Falda, M., Boccadoro, M., & Resegotti, L. (1996). Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma. European Journal of Haematology, 56(1-2), 39-44.

Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma. / Marmont, F.; Pich, A.; Chiusa, L.; Locatelli, F.; Falda, M.; Boccadoro, M.; Resegotti, L.

In: European Journal of Haematology, Vol. 56, No. 1-2, 1996, p. 39-44.

Research output: Contribution to journalArticle

Marmont, F, Pich, A, Chiusa, L, Locatelli, F, Falda, M, Boccadoro, M & Resegotti, L 1996, 'Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma', European Journal of Haematology, vol. 56, no. 1-2, pp. 39-44.
Marmont, F. ; Pich, A. ; Chiusa, L. ; Locatelli, F. ; Falda, M. ; Boccadoro, M. ; Resegotti, L. / Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma. In: European Journal of Haematology. 1996 ; Vol. 56, No. 1-2. pp. 39-44.
@article{b76985b6e54d4d8ca1d4c81d23090f52,
title = "Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma",
abstract = "The correlation between the bromodeoxyuridine (BrdU)-labelling index (LI) of plasma cells and a new proliferation marker, the Argyrophilic Nucleolar Organizer Regions (AgNORs), was investigated in 44 myeloma patients at diagnosis. A preliminary analysis was made to verify the reproducibility of the assessment of plasma cell infiltration (PC{\%}) in bone marrow aspirates, used to collect cells for LI determination, and in bone marrow biopsies, used for AgNORs evaluation. Although an overall good correlation was observed between PC{\%} in biopsies and aspirates (r = 0.58, p = 0.001), the ratio between PC{\%} in biopsies and in aspirates ranged from 0.35 to 7.5. Only 17 patients (38.6{\%}) were within the 0.5-1.5 range. A positive correlation between LI and AgNORs was observed in these patients (r = 0.68, p = 0.003), whereas the correlation was lost in patients with higher ratio between PC{\%} in biopsies and in aspirates (r = 0.08, p = 0.69). The prognostic significance of AgNORs was confirmed by survival analysis, showing a reduced survival for patients with high (> 4.4) AgNOR counts (14 months vs 35 months, p = 0.004). The AgNORs analysis therefore allows the simultaneous evaluation of myeloma cell infiltration, degree of differentiation and kinetics of growth in bone marrow biopsies. AgNOR counts deserve to be included in the procedures for diagnosis and prognostic evaluation of myeloma patients.",
keywords = "AgNORs, BrdU labelling index, Multiple myeloma, Prognosis",
author = "F. Marmont and A. Pich and L. Chiusa and F. Locatelli and M. Falda and M. Boccadoro and L. Resegotti",
year = "1996",
language = "English",
volume = "56",
pages = "39--44",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1-2",

}

TY - JOUR

T1 - Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma

AU - Marmont, F.

AU - Pich, A.

AU - Chiusa, L.

AU - Locatelli, F.

AU - Falda, M.

AU - Boccadoro, M.

AU - Resegotti, L.

PY - 1996

Y1 - 1996

N2 - The correlation between the bromodeoxyuridine (BrdU)-labelling index (LI) of plasma cells and a new proliferation marker, the Argyrophilic Nucleolar Organizer Regions (AgNORs), was investigated in 44 myeloma patients at diagnosis. A preliminary analysis was made to verify the reproducibility of the assessment of plasma cell infiltration (PC%) in bone marrow aspirates, used to collect cells for LI determination, and in bone marrow biopsies, used for AgNORs evaluation. Although an overall good correlation was observed between PC% in biopsies and aspirates (r = 0.58, p = 0.001), the ratio between PC% in biopsies and in aspirates ranged from 0.35 to 7.5. Only 17 patients (38.6%) were within the 0.5-1.5 range. A positive correlation between LI and AgNORs was observed in these patients (r = 0.68, p = 0.003), whereas the correlation was lost in patients with higher ratio between PC% in biopsies and in aspirates (r = 0.08, p = 0.69). The prognostic significance of AgNORs was confirmed by survival analysis, showing a reduced survival for patients with high (> 4.4) AgNOR counts (14 months vs 35 months, p = 0.004). The AgNORs analysis therefore allows the simultaneous evaluation of myeloma cell infiltration, degree of differentiation and kinetics of growth in bone marrow biopsies. AgNOR counts deserve to be included in the procedures for diagnosis and prognostic evaluation of myeloma patients.

AB - The correlation between the bromodeoxyuridine (BrdU)-labelling index (LI) of plasma cells and a new proliferation marker, the Argyrophilic Nucleolar Organizer Regions (AgNORs), was investigated in 44 myeloma patients at diagnosis. A preliminary analysis was made to verify the reproducibility of the assessment of plasma cell infiltration (PC%) in bone marrow aspirates, used to collect cells for LI determination, and in bone marrow biopsies, used for AgNORs evaluation. Although an overall good correlation was observed between PC% in biopsies and aspirates (r = 0.58, p = 0.001), the ratio between PC% in biopsies and in aspirates ranged from 0.35 to 7.5. Only 17 patients (38.6%) were within the 0.5-1.5 range. A positive correlation between LI and AgNORs was observed in these patients (r = 0.68, p = 0.003), whereas the correlation was lost in patients with higher ratio between PC% in biopsies and in aspirates (r = 0.08, p = 0.69). The prognostic significance of AgNORs was confirmed by survival analysis, showing a reduced survival for patients with high (> 4.4) AgNOR counts (14 months vs 35 months, p = 0.004). The AgNORs analysis therefore allows the simultaneous evaluation of myeloma cell infiltration, degree of differentiation and kinetics of growth in bone marrow biopsies. AgNOR counts deserve to be included in the procedures for diagnosis and prognostic evaluation of myeloma patients.

KW - AgNORs

KW - BrdU labelling index

KW - Multiple myeloma

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0029911818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029911818&partnerID=8YFLogxK

M3 - Article

C2 - 8599992

AN - SCOPUS:0029911818

VL - 56

SP - 39

EP - 44

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 1-2

ER -